About: http://data.cimple.eu/news-article/07861b3e84df3ef85a5a303d764da725da2495132bd524bddbae9168

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/07861b3e84df3ef85a5a303d764da725da2495132bd524bddbae9168 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up. Chinese manufacturers have been bullish about development, with companies Sinovac Biotech and Sinopharm even putting their vaccine candidates on display at a trade fair in Beijing this month. Representatives of the firms told AFP that they hope their vaccines will be approved after phase 3 trials as early as year-end. And on late Monday, the chief biosafety expert at the Chinese Centre for Disease Control told state broadcaster CCTV that a vaccine would be available to the general public "around November or December." Wu Guizhen did not specify which vaccine she was referring to, but said "based on the phase 3 clinical results, the current progress is very smooth." Wu added that she had taken a vaccine in April and has felt good over the past few months, although she did not specify which candidate she had taken. There are currently nine vaccine candidates in late-stage human trials, although some have hit recent obstacles -- pharma giant AstraZeneca and Oxford University momentarily paused clinical trials last week after a volunteer developed an unexplained illness. Some of China's vaccine candidates have already been offered to essential workers under an emergency use programme. A Sinovac spokesman told AFP this month that "tens of thousands" of people had voluntarily taken its vaccine, including 90 percent of its employees and their families -- between 2,000 and 3,000 people. In June, China's military approved a vaccine for use within its ranks developed by its research unit and a biotech firm. bys/rox/rma
schema:headline	China says Covid-19 vaccine could be ready for public by November
schema:mentions	Trade fair Agence France-Presse Beijing Sinovac Biotech University of Oxford AstraZeneca Vaccine China Coronavirus disease 2019 Biosafety China Central Television China National Pharmaceutical Group Qiang language
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-09-15 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	88 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software